DOCSLIB.ORG

A ABPA. See Allergic Bronchopulmonary Aspergillosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A ABPA. See Allergic Bronchopulmonary Aspergillosis Index A amyloidosis, 181–182 ABPA. See Allergic bronchopulmonary aspergillosis etiologies, 180 (ABPA) infections, 183–184 Acquired pulmonary vascular disease. See Non-throm- Mounier–Kuhn syndrome, 183 botic vascular diseases relapsing polychondritis, 182–183 Acute bilateral pulmonary embolism, 96 Saber–Sheath trachea, 181 Acute interstitial pneumonia (AIP), 202–203 tracheal neoplasms, 181–182 Acute pulmonary embolism, 95–96 tracheal stenosis, 180 Adenoidcystic carcinoma, 182 tracheobronchopathia Adenovirus pneumonia, 44 osteochondroplastica, 181–183 Adjuvant diagnostic testing tracheomalacia, 180–182 arterial blood gas, 98 Wegener granulomatosis, 183 ECG, 99 transitional zone, 179 transthoracic echocardiography, 99–100 Allergic bronchopulmonary aspergillosis (ABPA) troponin, 99 airway disease, 188 AIP. See Acute interstitial pneumonia (AIP) non-AIDS immunologic diseases Air embolism, 121–122, 125 clinical presentation, 261–262 Airway diseases diagnosis and management, 261–262 bronchial diseases obstructive pulmonary diseases, 165–166 bronchiectasis, 184–187 Amniotic fluid embolism (AE), 124–125 congenital structural defect, 186–187 Amyloidosis, 181–182 cystic fibrosis and related disorders, 188–189 Asbestosis, 212–213 impaired host defenses, 187–188 Aspergillus fumigatus tracheobronchitis, 184 infection, 186, 188 Asthma inhalational injury, 187 airway diseases, 190–192 local immunologic reactions, 189 bronchiectasis, 165 proximal airway obstruction, 186 chronic obstructive pulmonary disease, 162–168 systemic inflammatory disorders, 189 obstructive pulmonary diseases, 162–168 yellow nail syndrome, 189 occupational asthma, 222 conducting zone, 179 Atelectasis, 275–276 gas exchange zone, 179 Atrial fibrillation (AF), 130 small airways diseases Atypical infections. See Pulmonary infections asthma, 190–192 bronchiolitis, 189–190, 192 classification, 191 B thoracic anatomy Bacterial pneumonia central airway anomalies, 3–6 in HIV, 65–67 distal airways, 5 pulmonary disease, 65 trachea and central airways, 1–3 Behç et disease trachea hemoptysis, 241–242 J. P. Kanne (ed.), Clinically Oriented Pulmonary Imaging, 297 Respiratory Medicine, DOI: 10.1007/978-1-61779-542-8, Ó Humana Press, a part of Springer Science+Business Media, LLC 2012 298 Index B (cont.) ultrasound, 265 non-thrombotic vascular diseases, 109–110 lung Berylliosis, 220–221 aspiration, 275–276 BO. See Bronchiolitis obliterans (BO) atelectasis, 275–276 Bronchiectasis focal lung opacities, 275 airway disease, 184–187 pleural effusion, 275–276 asthma, 165 pneumonia, 275–276 hemoptysis, 234 pulmonary edema, 274–275 Bronchiolitis obliterans (BO), 198, 222–223 septic pulmonary emboli, 276–277 Broncholithiasis, hemoptysis, 234–235 mediastinum, cardiac abnormalities, 273–274 Bronchopneumonia and lobar pneumonia, 47 monitoring and support devices chest tubes, 269–272 endotracheal tube (ETT), 265–266 C enteric tubes, 272–273 Candida species, fungal pneumonia, 72 intra-aortic conterpulsation balloon, 268–270 Cardiomegaly, 273–274 mediastinal drains, 271–272 Castleman disease (CD) pulmonary artery catheters, 267–268, 270 clinical findings, 258–259 tracheostomy tubes, 266–267 diagnosis and management, 259–260 venous access catheters, 266–269 Central airway anomalies, 3–5 Cryptococcosis neoformans, 69 Centrilobular emphysema, 170 Cryptogenic organizing pneumonia (COP), 200–201 Centrilobular nodules, 44 CVID. See Common variable Chest CT, 174, 213, 217 immunodeficiency (CVID) Chronic bronchitis, 173–174 Cystic fibrosis, 185, 188–189 Chronic eosinophilic pneumonia, 166 Chronic obstructive pulmonary disease (COPD) asthma, 162–168 D chronic bronchitis, 173–174 Desquamative interstitial emphysema, 169–173 pneumonia (DIP), 201–202 Chronic pulmonary thromboembolic disease, 102 Diaphragm, 16 See also Pulmonary thromboembolic disease Diffuse alveolar hemorrhage (DAH), 239 Chronic thromboembolic pulmonary hypertension DIP. See Desquamative interstitial (CTEPH), 147 pneumonia (DIP) Churg–Strauss syndrome, 113–115, 167 Distal airways, 5–6 Chylothorax, 80–81 Coal workers’ pneumoconiosis (CWP), 216–219 Coccidioidomycosis immitis, 70 E Common variable immunodeficiency (CVID) Eisenmenger syndrome, 148, 151–152 clinical presentation, 252–253 Embolism diagnosis and management, 253–254 acute bilateral pulmonary embolism, 96 Community acquired pneumonia (CAP), 42, 47 acute pulmonary embolism, 95–96 Congenital pulmonary vascular disease air embolism, 121–122, 125 left pulmonary artery (LPA) sling, 105–107 amniotic fluid embolism, 124–125 partial anomalous pulmonary venous fat embolism, 123–124 return (PAPVR), 128–129 foreign body embolism, 122–123 pulmonary arteriovenous malformations non-thrombotic pulmonary embolism, 119 (PAVM), 106–107 pulmonary embolism, 100 scimitar syndrome, 129–130 septic embolism, 120–121, 124 unilateral proximal interruption, 106 subsegmental pulmonary embolism, 97 Congenital structural defect, 186–187 tumor embolism/intravascular pulmonary COP. See Cryptogenic organizing pneumonia (COP) metastases, 119–120, 123 COPD. See Chronic obstructive Emphysema, 54–55, 169–173 pulmonary disease (COPD) Empyema, 80 Critically ill ICU chest imaging, approach, 273 imaging modalities F computed tomography, 264–265 Fat embolism (FE), 123–124 magnet resonance imaging, 265 Fibrosing mediastinitis, 117, 123–124 portable radiography, 263–264 Fibrothorax, 83–84 Index 299 Follicular bronchiolitis I clinical presentation, 256 IASLC lymph node, 34 diagnosis and management, 256–257 Idiopathic interstitial pneumonias (IIP) Foreign body embolism, 122–123 acute interstitial pneumonia, 202–203 Fungal infections, hemoptysis, 237–238 cryptogenic organizing pneumonia, 200–201 Fungal pneumonia, 69, 72 desquamative interstitial pneumonia, 201–202 lymphoid interstitial pneumonia, 203–204 nonspecific interstitial pneumonia, 198–200 G respiratory bronchiolitis, 201–202 Gastroesophageal reflux disease, 164–165 respiratory bronchiolitis–interstitial lung disease, Goodpasture syndrome, 116–117, 239–240 201–202 Great vessels, 11–15 usual interstitial pneumonia, 196–199 Idiopathic pulmonary hemosiderosis (IPH), 241 IIP. See Idiopathic interstitial pneumonias (IIP) H Immunocompromise. See also Pulmonary infections Hantavirus cardiopulmonary syndrome, 43 duration and severity, 62 Hard metal disease/hard metal imaging appearances of pulmonary infections, 63 pneumoconiosis, 219–220 Immunosuppressed, 63 Hemoptysis See also Pulmonary infections coagulopathy, 244 Inadequate pulmonary artery opacification, 98 drug reaction, 244 Infarct, 243–244 latrogenic causes of, 245 Infections. See Pulmonary infections primary vascular Influenza pneumonia, 73 etiologies, 231 Intensive care, 263 pulmonary arteriovenous malformations, 242–243 See also Critically ill pulmonary embolus, 243 Interstitial lung disease (ILD), 201–202 pulmonary infarction, 243–244 Invasive Aspergillosis, 71–72 pulmonary parenchymal Behç et disease, 241–242 diffuse alveolar hemorrhage (DAH), 239 K etiologies of, 231 Kaposi sarcoma, 73–74 focal infection, 235 Kartagener syndrome, 188 fungal infections, 237–238 Goodpasture syndrome, 239–240 idiopathic pulmonary hemosiderosis, 241 L pulmonary abscess, 235–236 Left pulmonary artery (LPA) sling, 105–106 pulmonary contusion, 239 Lines, 274 sarcoidosis, 241 LIP. See Lymphoid interstitial pneumonia (LIP) systemic lupus erythematosis, 241 Low grade lymphoproliferative disorders, 256–257 tuberculosis, 236–237 Lung abscess, 56 Wegner granulomatosis, 240 Lung cancer radiation-induced lung injury, 244 imaging diagnosis, 30–31 tracheobronchial lymphoma, 75 acute and chronic bronchitis, 234 metastatic disease, 36–37 aspiration of foreign bodies, 235–236 nodal disease, 34–35 bronchiectasis, 234 nodal metastases, 35 broncholithiasis, 234–235 pathologic classification, 31–32 carcinoid, 233 primary tumor, 32–34 etiologies and diagnosis, 231 pulmonary neoplasm, 75 inflammatory, 233 screening, 31 neoplasm, 232–233 staging, 32 Hemothorax, 81 Lung parenchyma, 1–7 Henoch–Schönlein purpura, 115, 117 LYG. See Lymphomatoid granulomatosis (LYG) Hila, 15 Lymphadenopathy, 58 Histoplasmosis capsulatum, 69 Lymph node adjacent, 99 HIV, post transplant, 62 Lymphoid interstitial pneumonia (LIP), 203–204 HP. See Hypersensitivity pneumonitis (HP) clinical presentation, 257 Hydropneumothorax, 82 diagnosis and management, 257–259 Hypersensitivity pneumonitis (HP), 220–222 Lymphomatoid granulomatosis (LYG) 300 Index N (cont.) air embolism, 120–121, 125 clinical findings, 260 amniotic fluid embolism (AE), 124–125 diagnosis and management, 260–261 Behç et disease, 109–110 Churg–Strauss syndrome, 113–116 DAH, 116, 118 M fat embolism (FE), 123–124 Mediastinal biopsy, 286 fibrosing mediastinitis, 118–119 Mediastinum, 7–11 Goodpasture syndrome, 116 Mesothelioma, 86–87 Henoch–Schönlein purpura, 115, 117 Metastatic breast carcinoma, 85 large vessel vasculitis, 109 Metastatic renal cell carcinoma, 85 microscopic polyangiitis, 115 Microscopic polyangiitis, 115 non-thrombotic pulmonary embolism, 119 Miliary tuberculosis, pneumonia, 45 post radiofrequency catheter ablation pulmonary Mounier–Kuhn syndrome, 183 vein stenosis, 130–131 Mucormycosis, 70–71 pulmonary artery aneurysms and pseudoaneurysms, Multifocal adenocarcinoma, 47 116–120 Multiloculated empyema, 58 pulmonary artery sarcomas (PAS), 125–126 Mycobacterial infections, 50–53 pulmonary vasculitis, 107–111 Mycobacterium avium complex (MAC), 188 septic embolism, 120–121 Mycoplasma, 48–49 small vessel vasculitis, 110–111 systemic lupus erythematosus (SLE),, 116, 118 Takayasu arteritis, 110–112 N talc and other foreign body embolism,
Load more

Recommended publications
  • Pleural Effusion and Ventilation/Perfusion Scan Interpretation for Acute Pulmonary Embolus
    ventricular function by radionuclide angiography during exercise in normal subjects 33. Verani MS. Myocardial perfusion imaging versus two-dimensional echocardiography: and patients with chronic coronary heart disease. J Am Coll Cardiol 1983;1:1518- comparative value in the diagnosis of coronary artery disease. J NucíCardiol 1529. 1994;1:399-414. 29. Adam WE. Tarkowska A, Bitter F, Stauch M, Geffers H. Equilibrium (gated) 34. Foster T, McNeill AJ, Salustri A, et al. Simultaneous dobutamine stress echocardiog radionuclide ventriculography. Cardiovasc Radial 1979;2:161-173. raphy and technetium-99m SPECT in patients with suspected coronary artery disease. 30. Hurwitz RA, TrêvesS, Kuroc A. Right ventricular and left ventricular ejection fraction J Am Coll Cardiol I993;21:1591-I596. in pediatrie patients with normal hearts: first pass radionuclide angiography. Am 35. Marwick TH, D'Hondt AM, Mairesse GH, Baudhuin T, Wijins W, Detry JM, Meiin Heart J 1984;107:726-732. 31. Freeman ML, Palac R, Mason J, et al. A comparison of dobutamine infusion and JA. Comparative ability of dobutamine and exercise stress in inducing myocardial ischemia in active patients. Br Heart J 1994:72:31-38. supine bicycle exercise for radionuclide cardiac stress testing. Clin NucíMed 1984:9:251-255. 36. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic 32. Cohen JL, Greene TO, Ottenweller J, Binebaum SZ, Wilchfort SD, Kim CS. value of simultaneous stress dobutamine sestamibi single-photon-emission computer Dobutamine digital echocardiography for detecting coronary artery disease. Am J ized tomography and echocardiography in the detection of coronary artery disease.
    [Show full text]
  • Senior Thesis on the Artificial Pneumothorax Treatment of Acute Lobar Pneumonia
    University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1936 Senior thesis on the artificial pneumothorax treatment of acute lobar pneumonia Lawrence L. Anderson University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Anderson, Lawrence L., "Senior thesis on the artificial pneumothorax treatment of acute lobar pneumonia" (1936). MD Theses. 422. https://digitalcommons.unmc.edu/mdtheses/422 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. A Senior Thesis on the ARTIFICIAL PNEUi:lor.i:HORAX TR.EATMENT of ACUTE LOBAR PNEUMONIA With a review of the literature by Lawrence L. Anderson. 1936. Table of Contents Introduction - - - - - - - - - - - - - - - 1 History of Pnennonie 3 History of 2neumonia 'rherepy 5 History of Artificial Pneumothol"ax 9 Pneumothore.x in Pneumonia 11 (a review of the literature) Pathogenesis of Pneumonia 17 Rationale 24 Teclmique 31 Summary 36 Bibliography I 480744 1 Introduction The treetment of lobar pneumonia. has constit­ uted a harassing problerl to the Medical profession since the beGinning of 11'ledicine. As Osler' (39) said, tt Ever since the d8ys of antiquity, pneumonie has been observed and studied; while one method of treat­ ment after another has been vaunted with enthusiasm, only to be abandoned in despair; the disease mean­ while pursuing the even tenor of its way with scent regard for the treatment directed against it." That this statement, made thirty 'years ego, is still applica.ble today, is shown by the present mortality rate in this country.
    [Show full text]
  • Diagnosing Pulmonary Embolism M Riedel
    309 Postgrad Med J: first published as 10.1136/pgmj.2003.007955 on 10 June 2004. Downloaded from REVIEW Diagnosing pulmonary embolism M Riedel ............................................................................................................................... Postgrad Med J 2004;80:309–319. doi: 10.1136/pgmj.2003.007955 Objective testing for pulmonary embolism is necessary, embolism have a low long term risk of subse- quent VTE.2 5–7 because clinical assessment alone is unreliable and the consequences of misdiagnosis are serious. No single test RISK FACTORS AND RISK has ideal properties (100% sensitivity and specificity, no STRATIFICATION risk, low cost). Pulmonary angiography is regarded as the The factors predisposing to VTE broadly fit Virchow’s triad of venous stasis, injury to the final arbiter but is ill suited for diagnosing a disease vein wall, and enhanced coagulability of the present in only a third of patients in whom it is suspected. blood (box 1). The identification of risk factors Some tests are good for confirmation and some for aids clinical diagnosis of VTE and guides decisions about repeat testing in borderline exclusion of embolism; others are able to do both but are cases. Primary ‘‘thrombophilic’’ abnormalities often non-diagnostic. For optimal efficiency, choice of the need to interact with acquired risk factors before initial test should be guided by clinical assessment of the thrombosis occurs; they are usually discovered after the thromboembolic event. Therefore, the likelihood of embolism and by patient characteristics that risk of VTE is best assessed by recognising the may influence test accuracy. Standardised clinical presence of known ‘‘clinical’’ risk factors. estimates can be used to give a pre-test probability to However, investigations for thrombophilic dis- orders at follow up should be considered in those assess, after appropriate objective testing, the post-test without another apparent explanation.
    [Show full text]
  • An Interesting Case of Undiagnosed Pleural Effusion Case Report
    Amit Panjwani, Thuraya Zaid [email protected] Pulmonary Medicine, Salmaniya Medical Complex, Manama, Bahrain. An interesting case of undiagnosed pleural effusion Case report Pleural effusions are commonly encountered in the Investigations revealed a haemoglobin level Cite as: Panjwani A, Zaid T. clinical practise of both respiratory and nonrespiratory of 16.4 g⋅dL−1, and total leukocyte count of An interesting case of specialists. An estimated 1–1.5 million new cases in 8870 cells⋅mm−3 with a differential count of 62% undiagnosed pleural effusion. the USA and 200 000–250 000 new cases of pleural neutrophils, 28% lymphocytes, 7% monocytes, 2% Breathe 2017; 13: e46–e52. effusions are reported from the UK each year [1]. eosinophils and 1% basophils. The platelet count Analysis of the relevant clinical history, physical was 160 000 cells⋅mm−3. Creatinine, electrolytes examination, chest radiography and diagnostic and liver function tests were normal. The ECG was thoracentesis is useful in identifying the cause of unremarkable and cardiac enzymes were within pleural effusion in majority of the cases [2]. In a few normal limits. Chest radiograph (figure 1) showed a cases, the aetiology may be unclear after the initial mild, right-sided pleural effusion, blunting of the left assessment. The list of diseases that may account for costophrenic angle, no shift of mediastinal position a persistent undiagnosed pleural effusion is long [3]. and no lung parenchymal opacities. We present an interesting case of undiagnosed pleural effusion that was encountered in our hospital. R Case presentation A 33-year-old male presented to our hospital with a history of sudden-onset, pleuritic, right-sided chest pain of 2 days’ duration.
    [Show full text]
  • Postviral Bronchial Hyperreactivity Syndrome: Recognizing Asthma's
    • Postviral bronchial hyperreactivity syndrome: Recognizing asthmas great mimic DAVID OSTRANSKY, DO FRANCIS X. BLAIS, DO Although there are no prospec- (Key words: Viral infections, asthma, tive studies regarding the frequency of respiratory tract infections, postviral postviral bronchial hyperreactivity syn- bronchial hyperreactivity syndrome) drome, it is a common complication of upper and lower respiratory tract viral Viral respiratory tract infections frequently infections. The respiratory symptoms cause wheezing and other asthmalike symp- closely resemble those of asthma, but they toms. Several investigators have demonstrated are present for only 3 weeks to 3 months pertinent features of this abbreviated form of following the acute infection phase. Defin- asthma, including early response phase, late ing the mechanisms of this syndrome may response phase, and bronchial hyperreac- provide insight into the pathogenesis of tivity. 1-5 Understanding the mechanisms by asthma. Postviral bronchial hyperreac- which viral respiratory tract infections precipi- tivity syndrome is frequently misdiag- tate the airway abnormalities of asthma may nosed and inappropriately managed be- be a potential key to the pathogenesis of cause many physicians are unfamiliar asthma, although whether viral respiratory with this illness. Because of its character- tract infections truly cause asthma is un- istic history, diagnosis is straightforward proved.6 when the physician knows what to look The symptom complex following viral up- for, and response to therapy is excellent. per or lower respiratory tract infections (or This report presents a case history fol- both) has not been formally identified. It is fre- lowed by a review of the proposed mecha- quently misdiagnosed by physicians who then nisms of bronchial hyperreactivity follow- institute inappropriate diagnostic studies and ing viral respiratory infections.
    [Show full text]
  • Failure to Wean Caused by Cryptogenic Fibrosing Pleuritis and Bilateral Lung Trapping. Case Report*
    RBTI Relato DE CASO 2007:19:4:504-508 Failure to Wean Caused by Cryptogenic Fibrosing Pleuritis and Bilateral Lung Trapping. Case Report* Falência do Desmame em Paciente com Fibrose Pleural Idiopática e Trapping Pulmonar Bilateral. Relato de Caso Elsemiek Verweel1, Jos le Noble, PhD1, Christine Groeninx-van Zoelen1, Alex Maat2, Willy Thijsse1, Patricia Gerritsen1, Jan Bakker, PhD3 RESUMO Unitermos: decorticação pleural, fibrose pleural, fibro- se pulmonar, Fibrotórax Idiopático. JUSTIFICATIVA E OBJETIVOS: Fibrose pleural idiopá- tica é uma doença rara e pode afetar ambos pulmões SUMMARY já desde uma idade precoce. O achado mais comum na fibrose pleural idiopática é uma restrição pulmonar BACKGROUND AND OBJECTIVES: Cryptogenic fi -- grave que pode levar a um quadro de falência respira- brosing pleuritis is an extremely rare disease, which tória e hipoxemia. can affect both lungs from a very young age. The most RELATO DO CASO: Paciente do sexo masculino, 26 common finding is severe lung restriction resulting in anos, internado com reagudização de insuficiência both hypoxemic and ventilatory failure. respiratória crônica e submetido à ventilação mecâni- CASE REPORT: Male patient, 26 year old with acu- ca prolongada. Após intensa investigação e uma apre- te deterioration of chronic respiratory failure. Follo- sentação clínica atípica, foi estabelecido o diagnóstico wing admission prolonged mechanical ventilation de fibrose pleural idiopática associado à fibrose pul- was necessary. An atypical clinical presentation monar. made the diagnosis difficult, but eventually cryp- CONCLUSÕES: O prognóstico de pacientes com fi- togenic fibrosing pleuritis and lung fibrosis were brose pleural idiopática é extremamente ruim, particu- established. larmente em fase avançada da doença.
    [Show full text]
  • COVID-19 Pneumonia: the Great Radiological Mimicker
    Duzgun et al. Insights Imaging (2020) 11:118 https://doi.org/10.1186/s13244-020-00933-z Insights into Imaging EDUCATIONAL REVIEW Open Access COVID-19 pneumonia: the great radiological mimicker Selin Ardali Duzgun* , Gamze Durhan, Figen Basaran Demirkazik, Meltem Gulsun Akpinar and Orhan Macit Ariyurek Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread worldwide since December 2019. Although the reference diagnostic test is a real-time reverse transcription-polymerase chain reaction (RT-PCR), chest-computed tomography (CT) has been frequently used in diagnosis because of the low sensitivity rates of RT-PCR. CT fndings of COVID-19 are well described in the literature and include predominantly peripheral, bilateral ground-glass opacities (GGOs), combination of GGOs with consolida- tions, and/or septal thickening creating a “crazy-paving” pattern. Longitudinal changes of typical CT fndings and less reported fndings (air bronchograms, CT halo sign, and reverse halo sign) may mimic a wide range of lung patholo- gies radiologically. Moreover, accompanying and underlying lung abnormalities may interfere with the CT fndings of COVID-19 pneumonia. The diseases that COVID-19 pneumonia may mimic can be broadly classifed as infectious or non-infectious diseases (pulmonary edema, hemorrhage, neoplasms, organizing pneumonia, pulmonary alveolar proteinosis, sarcoidosis, pulmonary infarction, interstitial lung diseases, and aspiration pneumonia). We summarize the imaging fndings of COVID-19 and the aforementioned lung pathologies that COVID-19 pneumonia may mimic. We also discuss the features that may aid in the diferential diagnosis, as the disease continues to spread and will be one of our main diferential diagnoses some time more.
    [Show full text]
  • Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-Mail
    Central Annals of Clinical Pathology Bringing Excellence in Open Access Review Article *Corresponding author Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-mail: Biomarkers Submitted: 04 October 2018 Accepted: 31 October 2018 1,2 3 Attapon Cheepsattayakorn * and Ruangrong Cheepsattayakorn Published: 31 October 2018 1 10 Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand ISSN: 2373-9282 2 Department of Disease Control, Ministry of Public Health, Thailand Copyright 3 Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand © 2018 Cheepsattayakorn et al. OPEN ACCESS Abstract Ramazzini first described this disease, namely “Pneumonoultramicroscopicsilicovolcanokoniosis” Keywords and then was changed according to the types of exposed dust. No reliable figures on the silica- • Silicosis inhalation exposed individuals are officially documented. How silica particles stimulate pulmonary • Biomarkers response and the exact path physiology of silicosis are still not known and urgently require further • Pathogenesis research. Nevertheless, many researchers hypothesized that pulmonary alveolar macrophages play a major role by secreting fibroblast-stimulating factor and re-ingesting these ingested silica particles by the pulmonary alveolar macrophage with progressive magnification. Finally, ending up of the death of the pulmonary alveolar macrophages and the development of pulmonary fibrosis appear. Various mediators, such as CTGF, FBRS, FGF2/bFGF, and TNFα play a major role in the development of silica-induced pulmonary fibrosis. A hypothesis of silicosis-associated abnormal immunoglobulins has been postulated. In conclusion, novel studies on pathogenesis and biomarkers of silicosis are urgently needed for precise prevention and control of this silently threaten disease of the world.
    [Show full text]
  • Pediatric Pulmonology
    Received: 27 October 2019 | Accepted: 6 January 2020 DOI: 10.1002/ppul.24654 ORIGINAL ARTICLE: IMAGING Lung ultrasound—a new diagnostic modality in persistent tachypnea of infancy Emilia Urbankowska MD1 | Tomasz Urbankowski MD, PhD2 | Łukasz Drobczyński MD3 | Matthias Griese MD, PhD4 | Joanna Lange MD, PhD1 | Michał Brzewski MD, PhD5 | Marek Kulus MD, PhD1 | Katarzyna Krenke MD, PhD1 1Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Abstract Warsaw, Poland Lung ultrasound (LUS) has been increasingly used in diagnosing and monitoring of 2Department of Internal Medicine, various pulmonary diseases in children. The aim of the current study was to evaluate Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland its usefulness in children with persistent tachypnea of infancy (PTI). This was a 3Pediatric Radiology Department, Jan Polikarp controlled, prospective, cross‐sectional study that included children with PTI and Brudziński Pediatric Hospital, Warsaw, Poland healthy subjects. In patients with PTI, LUS was performed at baseline and then after 6 4Department of Pediatric Pneumology, Dr. von Hauner Children's Hospital, Ludwig‐ and 12 months of follow‐up. Baseline results of LUS were compared to (a) baseline Maximilians University, German Centre for high‐resolution computed tomography (HRCT) images, (b) LUS examinations in Lung Research (DZL), Munich, Germany ‐ 5Department of Pediatric Radiology, Medical control group, and (c) follow up LUS examinations. Twenty children with PTI were University of Warsaw, Warsaw, Poland enrolled. B‐lines were found in all children with PTI and in 11 (55%) control subjects ‐ Correspondence (P < .001). The total number of B lines, the maximal number of B lines in any Katarzyna Krenke, Department of Pediatric intercostal space, the distance between B‐lines, and pleural thickness were Pneumonology and Allergy, Medical University of Warsaw, Żwirki i Wigury 63A, significantly increased in children with PTI compared to controls.
    [Show full text]
  • Screening of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Silicosis by Discriminant Functions
    Eur Resplr J 1992, 5, 444-451 Screening of pulmonary hypertension in chronic obstructive pulmonary disease and silicosis by discriminant functions H. Evers, F. Liehs, K. Harzbecker, D. Wenzel, A. Wilke, W. Pielesch, J. Schauer, W. Nahrendorf, J. Preisler, A. Luther, D. Scheuler, W. Reimer, W. Schilling Screening of pulmonary hypertension in chronic obstructive pulmonary disease and Research Project Lung Diseases of the silicosis by discriminant functions. H. Evers, F. Liehs, K. Harzbecker, D. Wenzel, A. Ministry of Health, Berlin. Wilke, W. Pielesch, J. Schauer, W. Nahrendorf, J. Preisler, R. Luther, D. Scheuler, W. Reimer, W. Schilling. ABSTRACT: The aim of our prospective multicentric study was to develop a Correspondence: H. Evers Chest Clinic screening method for pulmonary hypertension in patients with chronic lung diseases. Str. nach Fichtenwalde 16 We investigated 710 patients in 10 hospitals: 315 males and 109 females with chronic D(o)·1504 Beelitz-Heilstiitten obstructive pulmonary disease, and 286 males with silicosis. Manifest pulmonary Germany. hypertension was defined as pulmonary artery pressure > 20 mmHg (2.7 kPa) at rest. The multivariate statistical method used was a stepwise discriminant analysis. In males with chronic obstructive pulmonary disease, the diameter of the right Keywords: descending pulmonary artery, forced expiratory volume in one second {FEV ) Chronic obstructive pulmonary disease 1 discriminant analysis ) arterial oxygen tension (Pao1 at rest, and age turned out to be relevant for dis­ crimilllltion of groups with and without manifest pulmonary hypertension. For pulmonary hypertension screening females the FEV/FVC (forced vital capacity) ratio replaced the absolute value of silicosis. FEV1 in the calculated discriminant function.
    [Show full text]
  • Severe Peripheral Neuropathy with Areflexic and Flaccid Quadriplegia Complicating Legionnaires' Disease in an Adult Patient
    Case Reports and Reviews Severe Peripheral Neuropathy With Areflexic and Flaccid Quadriplegia Complicating Legionnaires’ Disease in an Adult Patient Leonardo Calza, MD,* Elisabetta Briganti, MD,y Stefania Casolari, MD,y Roberto Manfredi, MD,* Giuseppe d’Orsi, MD,z Francesco Chiodo, MD,* and Tiziano Zauli, MDy (Infect Dis Clin Pract 2004;12:110–113) normalities, including brainstem and cerebellar dysfunction or peripheral nerve involvement, are relatively infrequent and tend to persist beyond resolution of acute clinical egionnaires’ disease is an acute systemic bacterial infec- manifestation.5–7 L tion that generally occurs as a severe lobar pneumonia An exceptional case of severe peripheral neuropathy associated with multisystemic extrapulmonary manifesta- with areflexic and flaccid quadriplegia in a middle-aged tions. Any species of the Legionellaceae family may cause woman with Legionnaires’ disease is described. this form of pneumonia in both normal and compromised hosts, but the most frequently pathogenic species is Legio- nella pneumophila that accounts for about 90% of all CASE REPORT human infection.1,2 A 48-year-old Caucasian female patient, who smoked about Ubiquitous in aquatic environments, the gram-negative 30 cigarettes daily, was hospitalized owing to persisting hyperpy- rexia, chills, asthenia, anorexia, and dry cough for about 5 days. Legionella organism is a facultative, intracellular parasite of Physical examination at the time of admission showed pe- freshwater protozoa such as the amoebae. The prevailing ripheral cyanosis, tachypnea, dyspnea, and a high body tempera- mode of transmission is probably by direct inhalation of ture (398C). Pulmonary auscultation revealed a respiratory silence aerosols that come from a water source (including air- at the right lung basis and diffuse, bilateral rales at the upper lobes.
    [Show full text]
  • Concurrent Silicosis and Pulmonary Mycosis at Death
    DISPATCHES B35–B49 (any mycosis). We defi ned pulmonary myco- Concurrent sis as death with ICD-9 and ICD-10 codes 112.4/B37.1 (candidiasis); 114/B38.0, B38.1, B38.2, B38.9 (coccid- Silicosis and ioidomycosis); 115/B39.0, B39.1, B39.2, B39.4, B39.9 (histoplasmosis); 116.0/B40.0, B40.1, B40.2, B40.9 (blas- Pulmonary tomycosis); 116.1/B41.0, B41.9 (paracoccidioidomyco- sis); 117.1/B42.0, B42.9 (sporotrichosis); 117.7/B46.0, Mycosis at Death B46.5, B46.9 (zygomycosis); 117.3/B44.0, B44.1, B44.9 Yulia Iossifova,1 Rachel Bailey, John Wood, (aspergillosis); 117.5/B45.0, B45.9 (cryptococcosis); and and Kathleen Kreiss 118/B48.7 (opportunistic mycoses). For many mycoses, ICD-9 codes do not differentiate pulmonary from other To examine risk for mycosis among persons with sili- types of mycoses. For ICD-10 codes, we limited data to cosis, we examined US mortality data for 1979–2004. Per- mycoses coded as pulmonary, opportunistic, and some sons with silicosis were more likely to die with pulmonary unspecifi ed type of mycoses (e.g., B38.9, B39.4, B39.9, mycosis than were those without pneumoconiosis or those with more common pneumoconioses. Health profession- B40.9, B41.9, B42.9, B44.9, B45.9, B46.5, and B46.9). als should consider enhanced risk for mycosis for silica- We provided results with and without ICD-9 code for op- exposed patients. portunistic mycoses and ICD-10 codes for unspecifi ed mycoses and opportunistic mycoses. We computed prevalence rate ratios and 95% con- he pneumoconioses are a group of irreversible but fi dence intervals (CIs) to separately compare pulmonary Tpreventable interstitial lung diseases, most commonly mycosis prevalence at death among persons with silicosis, associated with inhalation of asbestos fi bers, coal mine asbestosis, and CWP with that for persons in the refer- dust, or crystalline silica dust.
    [Show full text]